Interestingly, the EV proteomic profiling of patients suffering from MI revealed six potential proteins that could be exploited as biomarkers: these proteins are involved in lipid metabolism (APOD and APOC3), complement activation (C1Q1A and C5), and platelet activation pathways (GP1BA and PPBP). Here, APOD is linked to myocardial infarction.